Earnings
ABBV
106.15
-0.72%
-0.78
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
8.45B
30.00M
--
8.82B
--
--
0.00
--
3.31B
--
3.56B
--
24.17B
6.14B
--
293.00M
--
33.12B
82.88B
--
3.96B
126.39B
150.56B
--
2.28B
34.00M
--
--
--
6.52B
--
9.03B
--
--
--
2.33B
28.66B
77.55B
--
--
3.65B
27.61B
108.83B
137.47B
18.00M
17.38B
1.05B
-2.26B
--
21.00M
13.08B
13.10B
150.56B
FY 2019-12-31
39.92B
0.00
--
5.43B
--
--
0.00
--
1.81B
--
2.33B
22.00M
49.52B
3.31B
--
93.00M
--
15.60B
18.65B
--
1.94B
39.60B
89.11B
--
1.45B
0.00
--
--
--
3.13B
--
5.42B
--
--
--
1.83B
15.59B
62.98B
--
--
1.13B
17.60B
81.70B
97.29B
18.00M
15.19B
4.72B
-24.50B
--
--
-8.17B
-8.17B
89.11B
FY 2018-12-31
7.29B
772.00M
--
5.38B
--
--
0.00
--
1.60B
--
1.76B
132.00M
16.95B
2.88B
--
1.42B
--
15.66B
21.23B
--
1.21B
42.41B
59.35B
--
1.55B
3.70B
--
--
--
4.03B
--
4.73B
--
--
--
1.63B
17.24B
35.00B
--
--
1.07B
14.49B
50.56B
67.80B
18.00M
14.76B
3.37B
-24.11B
--
--
-8.45B
-8.45B
59.35B
FY 2017-12-31
9.30B
486.00M
--
5.09B
--
--
0.00
--
1.60B
--
4.72B
23.00M
21.22B
2.80B
--
2.09B
--
15.79B
27.56B
--
1.33B
49.56B
70.79B
--
1.47B
400.00M
--
--
--
3.63B
--
3.83B
--
--
--
1.29B
16.64B
30.95B
--
--
2.49B
15.61B
49.05B
65.69B
18.00M
14.27B
5.46B
-11.92B
--
--
5.10B
5.10B
70.79B
FY 2016-12-31
5.10B
1.32B
--
4.76B
--
--
0.00
--
1.44B
--
3.34B
225.00M
16.19B
2.60B
--
1.78B
--
15.42B
28.90B
--
1.21B
49.91B
66.10B
--
1.41B
377.00M
--
--
--
3.38B
--
3.53B
--
--
--
1.07B
9.78B
36.44B
--
--
6.89B
8.35B
51.68B
61.46B
18.00M
13.68B
4.38B
-10.85B
--
--
4.64B
4.64B
66.10B

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ABBV latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze AbbVie recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.